YUVEZZI
Live / Applied — Fourth extension granted (statement of use) (as of 30 Dec 2025)
What this means for you
Not registered yet, but its 19 Jan 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97760492
- Mark type
- Stylized text
- Filed
- 19 Jan 2023
- Published for opposition
- 21 Nov 2023
- Attorney of record
- Joshua G. Gigger
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the treatment of presbyopia; ophthalmological drugs; pharmaceutical preparations consisting of small molecules for the treatment of eye diseases and conditions; pharmaceutical preparations consisting of small molecules for the treatment of presbyopia
- Class 042 — Scientific and technological services: Providing medical and scientific research information in the field of presbyopia clinical trials and treatments
Owner
- Visus Therapeutics Inc., Seattle, WA, US
- Visus Therapeutics Inc., Seattle, WA, US
Prosecution history
- 27 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 27 Feb 2026 — TEAS STATEMENT OF USE RECEIVED
- 31 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Dec 2025 — SOU EXTENSION 4 GRANTED
- 30 Dec 2025 — SOU EXTENSION 4 FILED
- 30 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 28 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Jun 2025 — SOU EXTENSION 3 GRANTED
- 27 Jun 2025 — SOU EXTENSION 3 FILED
- 27 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 20 Nov 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Nov 2024 — SOU EXTENSION 2 GRANTED
- 20 Nov 2024 — SOU EXTENSION 2 FILED
- 20 Nov 2024 — SOU TEAS EXTENSION RECEIVED
- 16 Jul 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED